Literature DB >> 17885214

Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy.

Crystal M Ripplinger1, Wenwen Li, Jennifer Hadley, Junjie Chen, Florence Rothenberg, Raffaella Lombardi, Samuel A Wickline, Ali J Marian, Igor R Efimov.   

Abstract

Human hypertrophic cardiomyopathy, characterized by cardiac hypertrophy and myocyte disarray, is the most common cause of sudden cardiac death in the young. Hypertrophic cardiomyopathy is often caused by mutations in sarcomeric genes. We sought to determine arrhythmia propensity and underlying mechanisms contributing to arrhythmia in a transgenic (TG) rabbit model (beta-myosin heavy chain-Q403) of human hypertrophic cardiomyopathy. Langendorff-perfused hearts from TG (n=6) and wild-type (WT) rabbits (n=6) were optically mapped. The upper and lower limits of vulnerability, action potential duration (APD) restitution, and conduction velocity were measured. The transmural fiber angle shift was determined using diffusion tensor MRI. The transmural distribution of connexin 43 was quantified with immunohistochemistry. The upper limit of vulnerability was significantly increased in TG versus WT hearts (13.3+/-2.1 versus 7.4+/-2.3 V/cm; P=3.2e(-5)), whereas the lower limits of vulnerability were similar. APD restitution, conduction velocities, and anisotropy were also similar. Left ventricular transmural fiber rotation was significantly higher in TG versus WT hearts (95.6+/-10.9 degrees versus 79.2+/-7.8 degrees; P=0.039). The connexin 43 density was significantly increased in the mid-myocardium of TG hearts compared with WT (5.46+/-2.44% versus 2.68+/-0.77%; P=0.024), and similar densities were observed in the endo- and epicardium. Because a nearly 2-fold increase in upper limit of vulnerability was observed in the TG hearts without significant changes in APD restitution, conduction velocity, or the anisotropy ratio, we conclude that structural remodeling may underlie the elevated upper limit of vulnerability in human hypertrophic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885214      PMCID: PMC2366809          DOI: 10.1161/CIRCRESAHA.107.161240

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  32 in total

1.  Filament instability and rotational tissue anisotropy: A numerical study using detailed cardiac models.

Authors:  Wouter-Jan Rappel
Journal:  Chaos       Date:  2001-03       Impact factor: 3.642

2.  Dependence of local left ventricular wall mechanics on myocardial fiber orientation: a model study.

Authors:  P H Bovendeerd; T Arts; J M Huyghe; D H van Campen; R S Reneman
Journal:  J Biomech       Date:  1992-10       Impact factor: 2.712

3.  Regional ventricular wall thickening reflects changes in cardiac fiber and sheet structure during contraction: quantification with diffusion tensor MRI.

Authors:  Junjie Chen; Wei Liu; Huiying Zhang; Liz Lacy; Xiaoxia Yang; Sheng-Kwei Song; Samuel A Wickline; Xin Yu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-11       Impact factor: 4.733

4.  Altered connexin expression in human congestive heart failure.

Authors:  E Dupont; T Matsushita; R A Kaba; C Vozzi; S R Coppen; N Khan; R Kaprielian; M H Yacoub; N J Severs
Journal:  J Mol Cell Cardiol       Date:  2001-02       Impact factor: 5.000

5.  Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy.

Authors:  Atsushi Sanbe; Jeanne James; Volkan Tuzcu; Selman Nas; Lisa Martin; James Gulick; Hanna Osinska; Sadayappan Sakthivel; Raisa Klevitsky; Kenneth S Ginsburg; Donald M Bers; Bruce Zinman; Edward G Lakatta; Jeffrey Robbins
Journal:  Circulation       Date:  2005-05-02       Impact factor: 29.690

6.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  H Watkins; A Rosenzweig; D S Hwang; T Levi; W McKenna; C E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

7.  Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy.

Authors:  Adrian K Almquist; Julia V Montgomery; Tammy S Haas; Barry J Maron
Journal:  Heart Rhythm       Date:  2005-08       Impact factor: 6.343

8.  Myocardial vulnerability to T wave shocks: relation to shock strength, shock coupling interval, and dispersion of ventricular repolarization.

Authors:  C L Fabritz; P F Kirchhof; S Behrens; M Zabel; M R Franz
Journal:  J Cardiovasc Electrophysiol       Date:  1996-03

9.  Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.

Authors:  Sherif F Nagueh; Suetnee Chen; Rajnikant Patel; Natalia Tsybouleva; Silvia Lutucuta; Helen A Kopelen; William A Zoghbi; Miguel A Quiñones; Robert Roberts; A J Marian
Journal:  J Mol Cell Cardiol       Date:  2004-05       Impact factor: 5.000

10.  Effects of lidocaine on shock-induced vulnerability.

Authors:  Li Li; Vladimir Nikolski; Igor R Efimov
Journal:  J Cardiovasc Electrophysiol       Date:  2003-10
View more
  27 in total

1.  Novel micropatterned cardiac cell cultures with realistic ventricular microstructure.

Authors:  Nima Badie; Nenad Bursac
Journal:  Biophys J       Date:  2009-05-06       Impact factor: 4.033

Review 2.  On the emerging role of rabbit as human disease model and the instrumental role of novel transgenic tools.

Authors:  V Duranthon; N Beaujean; M Brunner; K E Odening; A Navarrete Santos; I Kacskovics; L Hiripi; E J Weinstein; Z Bosze
Journal:  Transgenic Res       Date:  2012-03-02       Impact factor: 2.788

3.  Robust T-tubulation and maturation of cardiomyocytes using tissue-engineered epicardial mimetics.

Authors:  Weining Bian; Nima Badie; Herman D Himel; Nenad Bursac
Journal:  Biomaterials       Date:  2014-02-06       Impact factor: 12.479

4.  Microstructural impact of ischemia and bone marrow-derived cell therapy revealed with diffusion tensor magnetic resonance imaging tractography of the heart in vivo.

Authors:  David E Sosnovik; Choukri Mekkaoui; Shuning Huang; Howard H Chen; Guangping Dai; Christian T Stoeck; Soeun Ngoy; Jian Guan; Ruopeng Wang; William J Kostis; Marcel P Jackowski; Van J Wedeen; Sebastian Kozerke; Ronglih Liao
Journal:  Circulation       Date:  2014-03-11       Impact factor: 29.690

5.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 6.  Experimental therapies in hypertrophic cardiomyopathy.

Authors:  Ali J Marian
Journal:  J Cardiovasc Transl Res       Date:  2009-10-01       Impact factor: 4.132

7.  The signal transduction cascade regulating the expression of the gap junction protein connexin43 by beta-adrenoceptors.

Authors:  A Salameh; S Krautblatter; S Karl; K Blanke; D Rojas Gomez; S Dhein; D Pfeiffer; J Janousek
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

8.  Electromechanical relationship in hypertrophic cardiomyopathy.

Authors:  Xiaoping Lin; Hsin-Yueh Liang; Aurelio Pinheiro; Veronica Dimaano; Lars Sorensen; Miguel Aon; Larisa G Tereshchenko; Yihan Chen; Meixiang Xiang; Theodore P Abraham; M Roselle Abraham
Journal:  J Cardiovasc Transl Res       Date:  2013-06-15       Impact factor: 4.132

Review 9.  Animal models of arrhythmogenic cardiomyopathy.

Authors:  Mark D McCauley; Xander H T Wehrens
Journal:  Dis Model Mech       Date:  2009 Nov-Dec       Impact factor: 5.758

Review 10.  Diffusion MR tractography of the heart.

Authors:  David E Sosnovik; Ruopeng Wang; Guangping Dai; Timothy G Reese; Van J Wedeen
Journal:  J Cardiovasc Magn Reson       Date:  2009-11-13       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.